Related Experiment Videos
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
Annalisa Chiocchetti1, Cristoforo Comi, Manuela Indelicato
1Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Sciences, A. Avogadro University of Eastern Piedmont, via Solaroli 17, I-28100 Novara, Italy.
Journal of Neuroimmunology
|May 12, 2005
Summary
Osteopontin (OPN) gene variations influence multiple sclerosis (MS) risk and progression. Haplotype-A homozygotes show reduced MS risk and slower disease advancement, linked to altered OPN levels.
Area of Science:
- Neuroimmunology
- Genetics of autoimmune diseases
- Cytokine biology
Background:
- Osteopontin (OPN) is an inflammatory cytokine implicated in multiple sclerosis (MS).
- Previous research identified OPN polymorphisms forming haplotypes A, B, and C, with haplotype-A homozygotes exhibiting lower OPN levels.
- The impact of these OPN genotypes on MS development and clinical course requires further investigation.
Purpose of the Study:
- To investigate the distribution of OPN haplotypes in a cohort of MS patients and healthy controls.
- To evaluate the association between OPN genotypes and the risk of developing MS.
- To analyze the correlation between OPN genotypes, OPN serum levels, and disease progression in MS patients.
Main Methods:
- Genotyping of OPN polymorphisms to determine haplotype frequencies in 425 MS patients and 688 controls.
- Clinical data analysis of 288 MS patients to assess disease progression and disability.
- Measurement of serum OPN levels in patients and controls stratified by OPN genotype.
Main Results:
- Haplotype-A homozygotes demonstrated a 1.5-fold lower risk of developing MS compared to non-AA subjects.
- AA genotype patients exhibited a slower transition from relapsing-remitting to secondary-progressive MS and a milder disease course with slower disability progression.
- MS patients generally had elevated OPN serum levels, with AA patients showing higher levels than AA controls, suggesting immune activation.
Conclusions:
- OPN genotypes significantly influence the risk and progression of multiple sclerosis.
- The OPN haplotype-A genotype is associated with reduced MS susceptibility and a more benign disease phenotype.
- These findings highlight the potential role of OPN genetic variations and their impact on OPN levels in MS pathogenesis.